Josh Raysman has joined our Scientific Advisory Board
- Thomas Lorenz
- Apr 24, 2024
- 1 min read
We are thrilled to announce that Josh Raysman has joined our Scientific Advisory Board! Josh brings a wealth of expertise from his significant experience in the digital health sector, previously leading initiatives within Pfizer’s Digital organization.
With his profound insights and innovative approach, Josh will be instrumental in guiding our mission to revolutionize medical diagnostics through our cutting-edge photonics technology. We look forward to his contributions and are excited to see how his expertise will help propel our advancements in cancer biomarker detection.
Welcome aboard, Josh! We are delighted to have you with us as we continue to push the boundaries of medical technology. 🚀
Comments